The crisis that began when a Dutch expedition cruise ship docked in the Canary Islands with a deadly hantavirus outbreak aboard has reached its end, at least for the Americans involved.
On June 24, 2026, the CDC officially concluded its hantavirus public health response, confirming that all 18 U.S. citizens who were potentially exposed to Andes virus during the MV Hondius cruise have completed their 42-day monitoring period without developing illness. All are home.
“The successful conclusion of this response demonstrates the strength of a coordinated response to infectious disease threats that occur outside of our borders,” said CDC Acting Director Jay Bhattacharya, MD, PhD, in the HHS announcement. “I am grateful for the world-class team at CDC whose dedication and swift action helped identify potential exposures, provide clear guidance, and protect the American people.”
Why This Matters
The MV Hondius outbreak represented the first significant cluster of Andes hantavirus cases outside of South America in modern public health history. It killed three people, required international contact tracing across seven countries, and tested the United States’ capacity for rapid infectious disease response in a way that had not been seen since the COVID-19 pandemic.
Andes virus is the only hantavirus known to transmit between people — a feature that made this outbreak particularly alarming to public health officials and different from the typical hantavirus exposure, which occurs from rodent contact.
The 42-day monitoring window — twice as long as the incubation period used for most other infectious diseases — reflected the scientific uncertainty about the outer limits of Andes virus incubation and the severity of the disease if it did develop.
What We Know So Far
According to the CDC’s hantavirus situation summary page and HHS announcement:
The MV Hondius departed from Ushuaia, Argentina on April 1, 2026, and traveled across the South Atlantic, stopping at multiple remote locations including Antarctica, South Georgia Island, and several Atlantic islands. The ship carried 147 people from 23 countries. The outbreak was first reported to the WHO on May 2, 2026.
A total of 13 confirmed cases occurred, including three deaths — all among passengers on the ship. The case fatality rate of approximately 23 percent is consistent with historical Andes virus data.
The CDC repatriated 18 potentially exposed American passengers via federal transport to the National Quarantine Unit (NQU) at the University of Nebraska Medical Center in Omaha. Twelve of those 18 were allowed to return home earlier to complete monitoring under their state health department’s supervision. Six remained at the NQU through the full 42-day period. All completed the period without developing disease.
On June 21, 2026, the 42-day monitoring period ended for all U.S. citizens. Three days later, the CDC formally concluded its response.
The Response: What Worked
The CDC transcript from the June 24 press conference described several response elements that were cited as successful:
- Rapid repatriation via dedicated federal transport, bypassing commercial aviation and reducing potential exposure to other passengers
- International coordination with public health authorities in seven countries to trace 188 high-risk contacts
- Deployment of CDC scientists to Argentina to trap and test rodents in areas connected to the outbreak, with the goal of identifying the original source of the Andes virus cluster
- Coordination between HHS, the State Department, ASPR, and state health departments across the United States
The response was facilitated by an HHS Public Readiness and Emergency Preparedness (PREP) Act declaration, which streamlined the deployment of medical countermeasures and investigational treatments.
The Context: Questions About Federal Capacity
As AJMC’s analysis noted, the response also prompted discussion about federal public health capacity — including recent CDC funding reductions and the U.S. withdrawal from the World Health Organization. CDC officials noted that those changes did not impede the hantavirus response, though independent observers noted that the outbreak tested response infrastructure that has been under significant budgetary and organizational stress.
The hantavirus response concluded smoothly. The ongoing Ebola outbreak in DRC — which the CDC has simultaneously been managing at growing scale — represents a continuing and accelerating test of the same infrastructure.
What the Science Says About Andes Virus
Andes virus causes hantavirus pulmonary syndrome (HPS), a severe respiratory disease with an approximate case fatality rate of 38 percent among those who develop the most severe symptoms. Among the MV Hondius cases, three of 13 died — a rate of approximately 23 percent.
There is no specific treatment for Andes virus infection. Management is entirely supportive: hospitalization, oxygen, and in severe cases, mechanical ventilation. No vaccine is currently approved or in late-stage development for Andes virus. Prevention in endemic areas of South America depends primarily on avoiding rodent contact and practicing respiratory precautions around symptomatic individuals.
What You Can Do Now
For most Americans, the closure of this response means there is no further action required. However, if you are planning expedition travel to South America — particularly Argentina, Chile, Patagonia, or other areas where Andes virus is endemic — review the CDC’s travel health guidance at CDC.gov/hantavirus before departure.
If you believe you have had potential exposure to hantavirus — whether through rodent contact or through someone with known Andes virus infection — contact your physician or state health department for guidance on monitoring.
What Happens Next
CDC scientists who traveled to Argentina as part of the investigation are analyzing environmental and rodent samples to better understand the outbreak’s origin. A formal report on the international response is expected to be published through the Eurosurveillance journal or CDC publication channels. MedicalDaily will report on the findings when they are published.
The Bottom Line
The United States monitored 18 potentially exposed Americans for 42 days — the maximum incubation period for Andes virus — and none developed illness. The CDC’s hantavirus response is officially over. The outcome is the best possible one: complete containment with zero U.S. cases. It reflects coordinated federal, state, and international work under a high-pressure, time-limited scenario. The response is worth recognizing — even as a larger Ebola outbreak now demands the same resources.
